Research Article
Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response
(a) Clinical characteristics of 11 TNBC tumors |
| LTQ Orbitrap sample ID | Patient age | Ethnicity | TR % | Response | T stage | Histological type | ER | PR | FISH R/G ratio | Neoadjuvant |
| #1 | 61 | White | 80 | R | T3 | IDC | |
−
| 1.10 | TC | #2 | 29 | Hispanic | −60 | NR | T3 | IDC |
−
|
−
| 0.92 | TC | #5 | 55 | Hispanic | 100 | R (pCR) | T3 | IDC |
−
|
−
| 0.92 | TC | #6 | 54 | Hispanic | 100 | R (pCR) | T3 | IDC |
−
|
−
| 1.01 | TC | #7 | 40 | Asian | 45 | IR | T3 | IDC |
−
|
−
| 1.17 | TC | #8 | 44 | White | | R (pCR) | T3 | IDC |
−
|
−
| 1.00 | TC | #9 | 49 | Hispanic | 48 | IR | T4 | IDC |
−
|
−
| 1.10 | TC | #10 | 53 | White | 100 | R (pCR) | T3 | IDC |
−
|
−
| 1.20 | TC | #11 | 84 | Asian | 100 | R (pCR) | T4 | IDC |
−
|
−
| 1.03 | TC | #36 | 45 | Hispanic | 30 | IR | T3 | IDC |
−
|
−
| 1.27 | TC | #37 | 38 | White | 100 | R (pCR) | T2 | IDC |
−
|
−
| 1.10 | TC |
|
|
aLN positive without residual primary cancer.
|
(b) Clinical characteristics of 28 HER2+ tumors |
| LTQ Orbitrap sample ID | Patient age | Ethnicity | TRR % | Response | T stage | Histological type | ER | PR | FISH R/G ratio | Neoadjuvant |
| #17 | 38 | White | 40 | IR | T3 | IDC | + |
−
| 12.4 | TC | #18 | 63 | Asian | 100 | R (pCR) | T3 | IDC | + |
−
| 12.7 | TCH | #19 | 57 | White | 100 | R (pCR) | T3 | IDC |
−
|
−
| 4.6 | TC | #20 | 56 | Asian | 78.2 | R | T4 | IDC | + |
−
| 10.71 | TC | #21 | 51 | Black | 56 | IR | T3 | IDC |
−
|
−
| 19.97 | TCH | #22 | 31 | White | 45.5 | IR | T3 | IDC | + | + | 2.2 | TC | #23 | 55 | White | 80 | R | T4 | IDC | + | + | 3.8 | TC | #24 | 45 | Asian | 75 | IR | T4 | IDC | + | + | 2.7 | TCH | #25 | 42 | Hispanic | 63.5 | IR | T4 | IDC | + |
−
| 2.5 | TC | #26 | 50 | White | 67.1 | IR | T3 | IDC |
−
|
−
| 2.41 | TCH | #27 | 33 | White | 82.9 | R | T3 | IDC | + | + | 3.03 | TCH | #28 | 40 | White | 66.7 | IR | T3 | IDC |
−
|
−
| 8.1 | TC | #29 | 35 | Hispanic | | R (pCR) | T3 | IDC |
−
|
−
| 42.2 | TCH | #30 | 44 | White | 97.3 | R | T4 | IDC |
−
|
−
| 4.2 | TC | #31 | 30 | White | −7.7 | NR | T3 | IDC | + |
−
| 5 | TC | #32 | 57 | White | 25% | NR | T4 | IDC | + |
−
| >4 | TCH | #33 | 37 | White | 33.3 | IR | T2 | IDC | + | + | 9.49 | TC | #34 | 36 | Black | 25 | NR | T3 | IDC |
−
|
−
| 5.1 | TC | #35 | 42 | White | 60 | IR | T2 | IDC | + | + | 4.5 | TCH | #38 | 55 | White | 42.3 | IR | T4 | IDC |
−
|
−
| 3.9 | TCH | #39 | 47 | White | | R (pCR) | T3 | IDC | + | + | >20 | TCH | #40 | 50 | Asian | | R (pCR) | T3 | IDC | + | + | 4.19 | TCH | #41 | 58 | White | 50 | IR | T4 | IDC | + | + | 2.1 | TCH | #42 | 40 | Asian | 60 | IR | T2 | IDC |
−
|
−
| 16 | TC | #43 | 37 | White | −85.6 | NR | T3 | IDC | + | + | 3.1 | TC | #44 | 49 | White | | R (pCR) | T2 | IDC | + |
−
| 7.7 | TCH | #45 | 55 | Asian | 92.6 | R | T3 | IDC |
−
|
−
| 9.9 | TC | #46 | 41 | Hispanic | 100 | R (pCR) | T2 | IDC |
−
|
−
| 9.2 | TC |
|
|
aLN positive and residual DCIS; bresidual DCIS only.
|